marches39 %Valneva collapses 39% after disappointing results in March

Valneva collapses 39% after disappointing results in March

Valneva's stock lost 39% of its value on March 23, 2026 following disappointing financial or clinical results.

Published 13sem1 sourceNotable

≈ 20sSpeed

The fact

This collapse reflects the risks inherent to publicly-traded biotech companies, particularly sensitive to pipeline announcements.

Investors abandoned the stock, questioning the company's future viability.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on April 18, 2026